Integrated Multi-Channel Automatic Cellular Profiling (iMAP) System for Cholangiocarcinoma Diagnosis
Moonhyun Choi1,2, Mi Ho Jeong1, Taehwang Son1
1Center for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Small (Weinheim an Der Bergstrasse, Germany)
|December 15, 2025
Summary
A new automated system, integrated multi-channel automatic cellular profiling (iMAP), enhances cholangiocarcinoma (CCA) diagnosis. This rapid, microfluidic-based technology improves diagnostic accuracy for this lethal bile duct cancer.
Area of Science:
- Oncology
- Biotechnology
- Medical Diagnostics
Background:
- Cholangiocarcinoma (CCA) is a deadly bile duct cancer with poor prognosis.
- Current diagnostic methods for CCA face challenges like late detection and low accuracy due to paucicellular specimens.
- There is a critical need for improved screening and diagnostic tools for CCA.
Purpose of the Study:
- To develop and validate an automated system for robust analysis of biliary specimens for CCA detection.
- To enhance the diagnostic accuracy and efficiency of CCA identification from endoscopic samples.
Main Methods:
- An integrated multi-channel automatic cellular profiling (iMAP) system was developed using microfluidic technology.
- The iMAP system automates cell enrichment, immunostaining, and molecular analysis of biliary brushing cytology samples.
- The process from sample loading to diagnosis is completed within 30 minutes.
Main Results:
- The iMAP system demonstrated good clinical diagnostic accuracy (AUC = 0.85) for CCA in a pilot study of 56 patient samples.
- A four-marker combination (MUC1, EpCAM, EGFR, MARS1) showed effectiveness in identifying CCA.
- The system successfully enriched epithelial cells while removing blood and fibrotic cells.
Conclusions:
- The automated iMAP system offers a rapid and accurate method for CCA diagnosis.
- iMAP can complement existing cytopathology workflows, reducing sample loss and improving diagnostic outcomes.
- This technology holds promise for earlier and more accurate detection of cholangiocarcinoma.


